(NaturalNews) Prevnar, an anti-pneumonia vaccination given in the United Kingdom, likely causes a significantly worse form of pneumonia to develop. This life-threatening lung disease, called Serotype 1, has become ten times more prevalent in ten years.
Serotype 1 pneumonia causes the pleura, the lining of the lungs, to become infected. The disease is suffered primarily by children, who experience fear from difficulty breathing and severe pain. Treatment consists of surgical debridement, that is, scraping, of the pleura to remove the noxious material.
In the UK, where the Prevnar vaccine has been aggressively and widely disseminated, pediatrician David Spencer has said, "It looks as if the Serotype one is becoming more virulent."
Testing Prevnar for Ear Infections
Although intended as an anti-pneumonia vaccine, Prevnar's manufacturer, Wyeth, has sold it largely for prevention of ear infections, otitis media. They developed a novel approach to testing for this purpose.
Rather than giving the control group a placebo, the guinea pigs received a different vaccine, the meningococcal group C conjugate vaccine (MnCC). The result was that the MnCC group, the so-called control group, had a 6-7 percent higher incidence of ear infections.
Aside from the fact that the difference in incidence of ear infections between the two groups is not great, an assumption was made that both vaccines prevent it. However, without comparison with people who did not receive either vaccine, there is no reason to believe that either one prevented disease. In fact, it could be that both actually cause otitis media, but that MnCC causes it more than Prevnar.
As it turns out, this may be exactly what is happening. Though sold as an ear infection preventative and tested in an excruciatingly twisted manner to "prove" it does prevent the disease, reports have been coming out showing that Prevnar actually causes otitis media. Worse, it's now a superbug.
On September 17, 2007, ABCmoney.co.uk reported an outbreak of ear infections caused by drug-resistant strep bacteria. What appears to be happening is that prevention of some kinds of pneumonia is allowing other, more virulent ones, to proliferate.
There are dozens of types of pneumonia bacteria. Prevnar prevents only seven of them, and far from the worst forms of the disease. As a result, some of these more virulent strains of pneumonia, which had been held in check by competition with the seven types that Prevnar destroys, are running rampant in children who have received the Prevnar vaccine. In other words, its success is creating a greater danger.
Prevnar is a perfect example of the law of unexpected consequences. Or were they unexpected?
According to an Associated Press report, Wyeth "anticipated" the spread of new strains of pneumonia and ear infection bacteria as a result of their vaccine! They are in the process of testing another one, and plan for its use by the general public in the next year or two. This one would address 18 strains of pneumonia-causing bacteria.
What happens then? There are more than 18 strains of pneumonia bacteria. What's the likelihood of even more virulent strains becoming prevalent as a result of "success" of the new vaccine? No one knows. Sadly, it appears that no one is going to address the issue. The FDA has given the go-ahead to Wyeth to do trials.
New Pneumonia Strain's Prevalence
Scientists analyzed over 21,000 samples from various places in the U.S. They found that incidence of the drug-resistant bacteria, called 19A, has been increasing. Worse, in children under age two, a full 15% of children carried 19A, up from 4% during the previous three years.
In 2004-2005, researchers at the University of Iowa found that 35% of penicillin-resistant infections were caused by 19A. The year before, 19A caused only 2%.
If this isn't bad enough, GlaxoSmithKline has yet another pneumonia vaccine in final testing in Europe.
Thanks to Wyeth, the FDA, and the entire medical system, we have a developing virulent and deadly pneumonia that's likely the direct result of a vaccine. Rather than taking a step back and considering withdrawing Prevnar, the approach in both the U.S. and U.K. has been to up the ante: develop another vaccine, presumably to cover more bacteria. There is no reason to believe that this won't result in an even more virulent strain of pneumonia than the one already created.
In fact, there's reason to believe that the situation could become far worse. Bacteria have the ability to transfer successful genes across species. Thus, antibiotic-resistant varieties can provide their resistance to other species of bacteria. As Baylor College of Medicine doctor, Daniel Musher, said, "New types may emerge that can both escape containment by vaccine and spread throughout the world."
It looks like a pharmaceutical firm has created the perfect vaccine, at least from their point of view. They make millions of dollars by convincing governments and doctors that it's going to save lives. Then, the vaccine creates an even worse disease. Of course –- from their point of view –- this "requires" the creation of yet another vaccine, from which they can make even more millions. It sounds like the perfect endless money-making by disease-creation loop –- at least, from the point of view of the drug companies.
Journal of the American Medical Association, "Postlicensure Safety Surveillance for 7-Valent Pneumococcal Conjugate Vaccine", Wise et al, 292(14):1702
About the author
* Heidi Stevenson, BSc, DIHom, FBIH * Fellow, British Institute of Homeopathy * Gaia Health (http://www.gaia-health.com) * * The author is a homeopath who became concerned with medically-induced harm as a result of her own experiences and those of family members. She says that allopathic medicine is the arena that best describes the motto, "Buyer beware." * * * Heidi Stevenson provides information about medically-induced disease and disability, along with incisive well-researched articles on major issues in the modern world, so members of the public can protect themselves. * She can be reached through her website: www.gaia-health.com